Biden pushes forward on Medicare price negotiation
But opposition from the drug industry and congressional Republicans could make the Democrats’ signature proposal an uphill battle.
How to alleviate clinical placement challenges & navigate uncertainty in the fall
Meet three programs navigating the potential headaches of Clinical Placements with ease.
4 ways ADT event notifications improve payer performance
Our all-in-one real-time health event notification solution allows payers to work alongside providers to ensure that their members are on a path to better health outcomes that reduces waste and frustration.
Hospital execs see delta pressure dragging into early fourth quarter: Jefferies poll
The variant is expected to peak late in the third quarter or early in the fourth, according to a survey of 40 hospital CEOs and CFOs conducted by the bank.
Biden, industry groups mandate COVID-19 vaccines for most healthcare workers
CMS and the Centers for Disease Control and Prevention are requiring that all provider facilities that participate in the Medicare and Medicaid programs vaccinate their workers, according to a Thursday release.
Biogen offered a window into what’s holding up Aduhelm. Investors didn’t like what they saw.
At Morgan Stanley’s healthcare conference, executives detailed how the launch of their Alzheimer’s drug has been slower than expected, due in large part to lingering questions about clinical trial data and insurance coverage.
Telehealth claims drop to lowest level since before pandemic, Fair Health finds
Virtual care claims fell from 5% of all medical claims in May to 4.5% in June, according to a tracker maintained by the nonprofit.
Pandemic relief funds were unevenly distributed, didn’t account for community burden: Health Affairs
Researchers analyzed HHS data on the Provider Relief Fund and found hospitals serving fewer patients with employer-sponsored insurance received less funding.
Industry pushes for more time before surprise billing ban enforced
Payers and hospitals say with the COVID-19 pandemic ongoing and key elements still unreleased, it will be difficult to comply by Jan. 1. Key sticking points include arbitration and qualified payment amounts.
Moderna expands mRNA vaccine supply in deal with new biotech producer
The company had previously said it could make up to 3 billion vaccine doses in 2022, depending on how booster shots are authorized.